- Filed
- Dec 26, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Dec 22, 2023 | 163.7M sh |
| Shares Diluted | Q1 2024 · Oct 31, 2023 | 161.53B sh |
| Shares Diluted restated | Q1 2024 · Oct 31, 2022 | 143.07B sh |
| Capex | Q1 2024 · Oct 31, 2023 | $96K |
| Capex | Q1 2024 · Oct 31, 2022 | $108K |
| Operating Cash Flow | Q1 2024 · Oct 31, 2023 | $282K |
| Operating Cash Flow | Q1 2024 · Oct 31, 2022 | −$858K |
| Cash And Equivalents | Q1 2024 · Oct 31, 2023 | $946K |
| Cash And Equivalents | Q1 2024 · Jul 31, 2023 | $924K |
| Stockholders Equity | Q1 2024 · Oct 31, 2023 | −$31.7M |
| Stockholders Equity | Q1 2024 · Jul 31, 2023 | −$27.61M |
| Current Liabilities | Q1 2024 · Oct 31, 2023 | $71.86M |
| Current Liabilities | Q1 2024 · Jul 31, 2023 | $67.6M |
| Total Liabilities | Q1 2024 · Oct 31, 2023 | $73.76M |
| Total Liabilities | Q1 2024 · Jul 31, 2023 | $69.28M |
| Current Assets | Q1 2024 · Oct 31, 2023 | $2.54M |
| Current Assets | Q1 2024 · Jul 31, 2023 | $2.32M |
| Total Assets | Q1 2024 · Oct 31, 2023 | $38.37M |
| Total Assets | Q1 2024 · Jul 31, 2023 | $38.37M |
| Eps Diluted | Q1 2024 · Oct 31, 2023 | −$0.03 |
| Eps Diluted | Q1 2024 · Oct 31, 2022 | −$0.03 |
| Eps Basic | Q1 2024 · Oct 31, 2023 | −$0.03 |
| Eps Basic | Q1 2024 · Oct 31, 2022 | −$0.03 |
| Sga Expense | Q1 2024 · Oct 31, 2023 | $4.19M |
| Sga Expense | Q1 2024 · Oct 31, 2022 | $4.14M |
| Net Income | Q1 2024 · Oct 31, 2023 | −$4.09M |
| Net Income | Q1 2024 · Oct 31, 2022 | −$4.98M |
| Operating Income | Q1 2024 · Oct 31, 2023 | −$799K |
| Operating Income | Q1 2024 · Oct 31, 2022 | −$400K |
| Revenue | Q1 2024 · Oct 31, 2023 | $7.65M |
| Revenue | Q1 2024 · Oct 31, 2022 | $8.13M |